Cargando…

HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia

Histone deacetylase 8 (HDAC8), a class I HDAC that modifies non-histone proteins such as p53, is highly expressed in different hematological neoplasms including a subtype of acute myeloid leukemia (AML) bearing inversion of chromosome 16 [inv(16)]. To investigate HDAC8 contribution to hematopoietic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spreafico, Marco, Gruszka, Alicja M., Valli, Debora, Mazzola, Mara, Deflorian, Gianluca, Quintè, Arianna, Totaro, Maria Grazia, Battaglia, Cristina, Alcalay, Myriam, Marozzi, Anna, Pistocchi, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498549/ https://www.ncbi.nlm.nih.gov/pubmed/33015043 http://dx.doi.org/10.3389/fcell.2020.00844

Ejemplares similares

Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia?
por: Valli, Debora, et al.
Publicado: (2020)

Enigmatic Ladies of the Rings: How Cohesin Dysfunction Affects Myeloid Neoplasms Insurgence
por: Pezzotta, Alex, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development
por: Barbieri, Elisa, et al.
Publicado: (2016)

The Genome-Wide Impact of Nipblb Loss-of-Function on Zebrafish Gene Expression
por: Spreafico, Marco, et al.
Publicado: (2020)

NIPBL: a new player in myeloid cell differentiation
por: Mazzola, Mara, et al.
Publicado: (2019)

AML1/ETO accelerates cell migration and impairs cell-to-cell adhesion and homing of hematopoietic stem/progenitor cells
por: Saia, Marco, et al.
Publicado: (2016)

The Tumor Suppressor PRDM5 Regulates Wnt Signaling at Early Stages of Zebrafish Development
por: Meani, Natalia, et al.
Publicado: (2009)

Generation of a Triadin KnockOut Syndrome Zebrafish Model
por: Vecchi, Vanilla Martina, et al.
Publicado: (2021)

Combined Inhibition of Hedgehog and HDAC6: In Vitro and In Vivo Studies Reveal a New Role for Lysosomal Stress in Reducing Glioblastoma Cell Viability
por: Pezzotta, Alex, et al.
Publicado: (2023)

Dysregulation of NIPBL leads to impaired RUNX1 expression and haematopoietic defects
por: Mazzola, Mara, et al.
Publicado: (2020)

Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma – a case report
por: Gruszka, Alicja M., et al.
Publicado: (2015)

Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model
por: Cafora, Marco, et al.
Publicado: (2019)

The promise and perils of HDAC inhibitors in neurodegeneration
por: Didonna, Alessandro, et al.
Publicado: (2015)

HDAC Inhibitors in Acute Myeloid Leukemia
por: San José-Enériz, Edurne, et al.
Publicado: (2019)

A Novel Platform to Test In Vivo Single Gene Dependencies in t(8,21) and t(15,17) AML Confirms Zeb2 as Leukemia Target
por: De Conti, Giulia, et al.
Publicado: (2020)

Targeting HDACs: A Promising Therapy for Alzheimer's Disease
por: Xu, Ke, et al.
Publicado: (2011)

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
por: Mayr, Christian, et al.
Publicado: (2021)

HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
por: Losson, Hélène, et al.
Publicado: (2020)

P656: NOVEL THIAZOLIDINEDIONE WITH HDAC INHIBITING PROPERTIES OPTIMIZED FOR CHRONIC MYELOID LEUKEMIA TREATMENT
por: Rams, Anna, et al.
Publicado: (2023)

The Histone H3 Lysine 27-Specific Demethylase Jmjd3 Is Required for Neural Commitment
por: Burgold, Thomas, et al.
Publicado: (2008)

MITO-Luc/GFP zebrafish model to assess spatial and temporal evolution of cell proliferation in vivo
por: de Latouliere, Luisa, et al.
Publicado: (2021)

HDAC2‐dependent miRNA signature in acute myeloid leukemia
por: Conte, Mariarosaria, et al.
Publicado: (2019)

From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
por: McIntyre, Rebecca L, et al.
Publicado: (2019)

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma
por: Palamaris, Kostas, et al.
Publicado: (2022)

Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

HDAC Inhibition by LBH589 Affects Phenotype and Function of Human Myeloid Dendritic Cells
por: Song, W, et al.
Publicado: (2010)

Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
por: Seo, Jinwon, et al.
Publicado: (2014)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells
por: Cea, Michele, et al.
Publicado: (2011)

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma
por: Heijkants, Renier, et al.
Publicado: (2017)

Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy
por: Wang, Zechen, et al.
Publicado: (2023)

HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation
por: Huang, Y, et al.
Publicado: (2014)

Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease
por: Elfiky, Ahmed M I, et al.
Publicado: (2021)

Pharmacologic inhibition of vacuolar H+ ATPase reduces physiologic and oncogenic Notch signaling
por: Kobia, Francis, et al.
Publicado: (2013)

Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson’s Disease?
por: Alselehdar, Samar K., et al.
Publicado: (2021)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia
por: Gu, Siyu, et al.
Publicado: (2023)

prox1b Activity Is Essential in Zebrafish Lymphangiogenesis
por: Giacco, Luca Del, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b1qnldt4mloom7f26p82q6jfs7